What is Amylyx Pharmaceuticals, Inc.'s PP&E (net)?

Amylyx Pharmaceuticals, Inc. (AMLX) reported PP&E (net) of $212K in Q1 2026.

How has Amylyx Pharmaceuticals, Inc.'s PP&E (net) changed year-over-year?

Amylyx Pharmaceuticals, Inc.'s PP&E (net) decreased by 74.0% year-over-year, from $816K to $212K.

What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s PP&E (net)?

Over 4 years (2021 to 2025), Amylyx Pharmaceuticals, Inc.'s PP&E (net) has grown at a -10.1% compound annual growth rate (CAGR), from $474K to $310K.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Amylyx Pharmaceuticals, Inc. AMLX PP&E (Net)

PP&E (Net) at other companies

MBX Biosciences, Inc.MBX

$3.13M+108%

Beam TherapeuticsBEAM

$101.25M-7.6%

Crinetics PharmaceuticalsCRNX

$13.5M+6.9%

Agios PharmaceuticalsAGIO

$10.57M-4.5%

Rhythm Pharmaceuticals, Inc.RYTM

$1.07M+131%

Taysha Gene Therapies, Inc.TSHA

$6.45M-10.9%

Other financials

Income statement

See full

Revenue-—

Gross profit-—

Operating income-$43.8M-15.8%

Net income-$41.3M-15.0%

EPS (diluted)-$0.37+11.9%

Balance sheet

See full

Cash & equivalents$229.1M+283%

Total debt$5.6M+307%

Total equity$273.2M+35.6%

Total assets$293.6M+33.7%

Cash flow

See full

Operating cash flow-$36.9M+7.4%

CapEx$86.0K+330%

Free cash flow-$28.0M+52.6%

Valuation

See full

Market cap$1.82B+390%

Enterprise value$1.6B+414%

Profitability

See full

Gross margin100%+6.9pp

Operating margin-47,349.8%-47,409pp

Net margin-45,096.2%-45,152pp

FCF margin-39,826.7%-39,847pp

Returns & leverage

See full

Return on equity-63.3%-12.2pp

Debt / equity0×0.0×

Current ratio17.9×+5.8×

Where this comes from

Reported directly by Amylyx Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amylyx Pharmaceuticals, Inc.'s pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Amylyx Pharmaceuticals, Inc.'s PP&E (net)?: Amylyx Pharmaceuticals, Inc. (AMLX) reported PP&E (net) of $212K in Q1 2026.
How has Amylyx Pharmaceuticals, Inc.'s PP&E (net) changed year-over-year?: Amylyx Pharmaceuticals, Inc.'s PP&E (net) decreased by 74.0% year-over-year, from $816K to $212K.
What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s PP&E (net)?: Over 4 years (2021 to 2025), Amylyx Pharmaceuticals, Inc.'s PP&E (net) has grown at a -10.1% compound annual growth rate (CAGR), from $474K to $310K.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.